DEVELOPMENTAL NEUROPSYCHOLOGY (ISSN: 8756-5641; E-ISSN: 1532-6942) is a pivotal peer-reviewed journal published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD in the United Kingdom. Since its inception in 1985, this esteemed journal has been dedicated to advancing the understanding of developmental processes that influence neuropsychological outcomes in children and adolescents. With a focus on the integration of psychological and neuropsychological perspectives, it serves as a vital resource for researchers, clinicians, and educators alike. The journal's current impact factor and its placement in the third quartile for both Developmental and Educational Psychology and Neuropsychology categories underscore its significance in the field, as it ranks in the 45th percentile in both Scopus ranks. While DEVELOPMENTAL NEUROPSYCHOLOGY does not offer open access, it presents crucial research findings and theoretical advancements that cater to professionals seeking to deepen their knowledge and application of developmental neuropsychology until 2024. By fostering dialogue among scholars and practitioners, this journal contributes meaningfully to the ongoing evolution of clinical practices and educational strategies targeting neurodevelopmental trajectories.

Developmental Cognitive Neuroscience is a leading interdisciplinary journal published by ELSEVIER SCI LTD, dedicated to advancing the field of cognitive neuroscience with a specific focus on the developmental aspects of brain function and behavior. Since its inception in 2011, this Open Access journal has continued to thrive, gaining significant recognition with a remarkable impact factor that places it in the Q1 category of cognitive neuroscience, ranking 22nd out of 115 in Scopus. This enhances its visibility and accessibility to a global audience, including researchers, clinicians, and students keen on exploring the intricate relationship between cognitive development and neurological processes. The journal embraces a wide array of topics, from the impact of early life experiences on cognitive outcomes to neurodevelopmental disorders, fostering an enriching platform for disseminating high-quality research and innovative findings. As it progresses towards 2024, Developmental Cognitive Neuroscience remains pivotal in shaping future research and understanding in the field.

The Journal of Developmental Origins of Health and Disease is a premier academic publication under the esteemed Cambridge University Press, dedicated to advancing the understanding of how developmental processes influence health outcomes across the lifespan. With an ISSN of 2040-1744 and an E-ISSN of 2040-1752, this journal has established itself as a critical resource in the field of medicine, currently positioned in the Q2 category of Medicine (miscellaneous). Having converged from 2010 to 2024, this journal reflects a significant commitment to exploring the interconnections between early development and subsequent health conditions. Ranked 147 out of 398 in its category according to Scopus, it retains a commendable 63rd percentile status, highlighting its contributions to this rapidly evolving field. Though it does not offer open access, the journal remains a vital platform for researchers, professionals, and students interested in uncovering the intricate links between developmental biology and public health challenges.

Drug and Chemical Toxicology is a well-respected journal in the fields of toxicology, pharmacology, and public health, published by Taylor & Francis Ltd. Since its inception in 1978, this journal has diligently explored the effects and mechanisms of chemical exposures on health and the environment, fulfilling a crucial role in advancing scientific understanding and safeguarding public health. The journal is indexed across prestigious databases and features an impressive array of articles categorized within the Q2 and Q3 quartiles across various categories in 2023, reflecting its significance in Chemical Health and Safety as well as Environmental and Occupational Health disciplines. With an extensive reach and a focus on interdisciplinary research, Drug and Chemical Toxicology offers a rich repository of original research, reviews, and methodological advancements, catering to a diverse audience of researchers, professionals, and students dedicated to the betterment of safety and health standards. Although not an open-access publication, its articles are widely accessible to the academic community, ensuring that critical innovations and insights are shared for the greater good.

Behavioral and Brain Functions is a leading Open Access journal published by BMC, dedicated to advancing the field of behavioral neuroscience, cognitive neuroscience, and biological psychiatry since its inception in 2005. This esteemed journal, based in the United Kingdom, has established itself as a vital resource for researchers and professionals, boasting a remarkable influence demonstrated by its Q1 and Q2 rankings across multiple relevant categories. With its commitment to providing unrestricted access to high-quality research, the journal facilitates the dissemination of significant findings in understanding the complex interactions between behavior and brain function. The journal ranks impressively within the Scopus database, positioning itself among the top-tier publications in its categories, making it an essential platform for academic discourse and innovation. As it converges through 2024, Behavioral and Brain Functions continues to play a crucial role in shaping the forefront of neuroscientific inquiry, inviting contributions that challenge our understanding and promote further exploration in these dynamic fields.

Comparative Biochemistry and Physiology C-Toxicology & Pharmacology, published by Elsevier Science Inc, stands as a prominent resource in the fields of pharmacology, toxicology, and biochemical research. With its ISSN 1532-0456 and E-ISSN 1878-1659, this journal has carved out a significant niche, focusing on the comparative aspects of biochemical and physiological data across various species. Recognized for its impact in diverse fields, it boasts a Q1 ranking in Animal Science and Zoology, Aquatic Science, Health, Toxicology and Mutagenesis, alongside respectable standings in other related disciplines. Researchers and professionals can leverage this publication to access high-quality, peer-reviewed studies that advance the understanding of biochemical processes and their toxicological implications. The journal aims to bridge the gap between laboratory findings and real-world applications, fostering an environment for interdisciplinary collaboration. For academics seeking to enhance their knowledge or contribute to this impactful field, Comparative Biochemistry and Physiology C-Toxicology & Pharmacology serves as an invaluable platform.

Toxicology and Environmental Health Sciences is a peer-reviewed journal published by the Korean Society for Environmental Risk Assessment & Health Science, dedicated to advancing the fields of toxicology and environmental health. With an ISSN of 2005-9752 and E-ISSN 2233-7784, this journal serves as a vital platform for researchers, professionals, and students seeking to explore the intricate relationships between environmental risks and public health. Operating from South Korea, it has a converged years span from 2009 to 2024, and currently holds a respectable Q3 quartile ranking in both Health, Toxicology and Mutagenesis and Toxicology. This positions the journal within a critical space for those invested in understanding and mitigating environmental health challenges. Although not an open-access journal, it continues to foster high-impact research, contributing to a better understanding of toxicological sciences and environmental health dynamics. Engage with the latest findings and discussions that shape this evolving field through the insightful articles published herein, reinforcing its importance as a resource for scholars and practitioners alike.

TOXICOLOGY AND APPLIED PHARMACOLOGY, published by Academic Press, Inc. Elsevier Science, stands as a leading journal in the domains of toxicology and pharmacology, with its establishment dating back to 1959. With an impact factor reflecting its academic rigor and relevance, this journal is classified in the Q2 quartile for both pharmacology and toxicology categories, underscoring its significance in the scientific community. It ranks #34 out of 133 in Toxicology and #95 out of 313 in Pharmacology according to Scopus, placing it within the 74th and 69th percentiles, respectively. The journal aims to disseminate quality research that drives advancements in understanding the interactions of drugs and toxic substances within biological systems. Researchers and professionals are invited to contribute and engage with a broad spectrum of articles that cover mechanistic studies, risk assessment, and innovative therapeutic strategies. Although the journal does not offer open access, it continues to be a crucial resource for those who seek to navigate the complex interface of drugs and their toxicological implications.

NEUROTOXICITY RESEARCH is a premier journal published by SPRINGER, focusing on the critical and evolving field of neurotoxicology. With an ISSN of 1029-8428 and an E-ISSN of 1476-3524, this journal serves as a vital platform for researchers, professionals, and students dedicated to understanding the impact of toxic substances on nervous system health. Established in 1999, NEUROTOXICITY RESEARCH has consistently contributed significant findings and discussions that influence both theoretical and applied neuroscience. The journal's impressive Q2 ranking in both Neuroscience (miscellaneous) and Toxicology categories, alongside its strong percentile rankings in Scopus, underscores its relevance and quality in the academic community. While this journal is not open access, it remains a critical resource for those seeking interdisciplinary insights into the mechanisms of neurotoxicity. The objective of NEUROTOXICITY RESEARCH is to elucidate the intricate interactions between environmental and chemical agents and their neurotoxic effects, guiding future research and policies aimed at safeguarding neurological health. Based in the United States at ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY 10004, this journal is committed to advancing the understanding of neurotoxic mechanisms and fostering collaborative efforts within the scientific community.

Welcome to the JOURNAL OF COGNITIVE NEUROSCIENCE, a premier publication in the field of cognitive neuroscience, published by the esteemed MIT PRESS. Since its inception in 1989, this journal has been at the forefront of advancing our understanding of the neural mechanisms underlying cognitive processes, boasting an impressive convergence period through 2024. With its Q1 ranking in the 2023 cognitive neuroscience category, it stands out among 115 peers, indicating its critical role in shaping contemporary research. The journal offers a comprehensive array of research articles, reviews, and methodologies aimed at researchers, professionals, and students alike, facilitating the exploration of complex cognitive functions. While not an open-access journal, it provides essential insights and significant contributions to the neuroscience community, making it an invaluable resource for anyone keen on delving into the intricacies of the human brain.